Stock Price Quote

DR. LAL PATHLABS LTD.

NSE : LALPATHLABBSE : 539524ISIN CODE : INE600L01024Industry : Hospital & Healthcare ServicesHouse : Arvind Lal
BSE2228.80-11.3 (-0.5 %)
PREV CLOSE ( ) 2240.10
OPEN PRICE ( ) 2245.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3195
TODAY'S LOW / HIGH ( )2204.00 2257.25
52 WK LOW / HIGH ( )1181.8 2395
NSE2228.70-9.25 (-0.41 %)
PREV CLOSE( ) 2237.95
OPEN PRICE ( ) 2238.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 2228.70 (286)
VOLUME 61594
TODAY'S LOW / HIGH( ) 2205.05 2269.00
52 WK LOW / HIGH ( )1179.55 2394.7
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 14-02 1995
Management Info
Arvind Lal - Chairman Om Prakash Manchanda - Managing Director
Registered Office

Address Block E,Sector 18,Rohini,
New Delhi,
Delhi-110085

Phone 91-011-3024 4149

Email ved.goel@lalpathlabs.com

Website www.lalpathlabs.com

Registrars Details
Link Intime India Pvt Ltd.
Noble Heights, 1st Floor, Plot NH 2,C-1 Block LSC, Near Savitri Market,Janakpuri,New Delhi
Listing : BSE, NSE

NEWS

24Nov Dr.Lal Pathlabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
23Nov Dr. Lal Pathlabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
06Nov Dr. Lal PathLabs’ arm signs binding te
PathLabs Unifiers (PUPL), a wholly owned subsidiary of Dr. Lal PathLabs,..
25Sep Dr. Lal Pathlabs informs about analyst
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Re..
23Sep Dr Lal Pathlabs informs about analyst
Dr Lal Pathlabs has informed that pursuant to Regulation 30 of SEBI (Lis..

Financials

in Millions
QTR Sep 20 ANNUAL 20
Net Profit7992232
Gross Profit 1068 3027
Operating Profit 12823854
Net Sales 404312736

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Apollo Hospital Ent. (BSE)
peergroup  2301.55 (2.67%)
M.Cap ( in Cr)32020.35
Kovai Medical Center (BSE)
peergroup  990.15 (0.37%)
M.Cap ( in Cr)1083.45
Fortis Healthcare (BSE)
peergroup  148.05 (1.79%)
M.Cap ( in Cr)11177.16
Dr Agarwals Eye Hsp (BSE)
peergroup  240.50 (0.73%)
M.Cap ( in Cr)113.04
Artemis Medicare (BSE)
peergroup  160.75 (0.88%)
M.Cap ( in Cr)212.80

Shareholding Pattern

MUTUAL FUNDS/UTI 6.53%
PROMOTERS 55.23%
NON-INSTITUTION 12.73%
FI/BANKS/INSURANCE 1.29%
GOVERNMENT 0%
FII 0%

About Dr. Lal Pathlabs Ltd.

Dr. Lal Pathlabs Ltd. was incorporated in the year 1995. Its today's share price is 2240.1. Its current market capitalisation stands at Rs 18575.91 Cr. In the latest quarter, company has reported Gross Sales of Rs. 13303.57 Cr and Total Income of Rs.13854.02 Cr. The company's management includes Anoop Singh, Archana Lal Erdmann, Rahul Sharma, Harneet Singh Chandhoke, Somya Satsangi, Saurabh Srivastava, Sunil Varma, Vandana Lal, Om Prakash Manchanda, Arvind Lal.

It is listed on the BSE with a BSE Code of 539524 , NSE with an NSE Symbol of LALPATHLAB and ISIN of INE600L01024. It's Registered office is at Block E,Sector 18,RohiniNew Delhi-110085, Delhi. Their Registrars are ACC Ltd. It's auditors are Deloitte Haskins & Sells LLP, SR Batliboi & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)